Dr. Nikolaos Stergiopulos received his M.S. in Mechanical Engineering from the National Technical University of Athens, Greece, in 1985, and his Ph.D. in Biomedical Engineering from Iowa State University, USA, in 1990. Nikos Stergiopulos also holds a degree in Management of Technology from the IMD. He is currently a full Professor and Director of the Laboratory of Hemodynamics and Cardiovascular Technology at the Swiss Federal Institute of Technology in Lausanne, Switzerland. His main research interests are Hemodynamics, Cardiovascular Mechanics, and Medical Implant Technology. He has authored more than 200 peer-reviewed papers and holds more than 20 patents in medical technology. In 1998, he co-founded EndoArt SA, a medical device startup company, a world leader in telemetrically powered and controlled medical implants for the treatment of congenital heart disease and morbid obesity. He is currently the founder and managing director of Rheon Medical SA, and developer of an adjustable drainage device for the surgical treatment of glaucoma. He is also the founder and CSO of Comphya SA, a MedTech startup developing an implantable electrostimulation device for the treatment of erectile dysfunction.